Travere Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $11M | 749k | 13.99 |
| 2024-06-30 | $6.5M | 785k | 8.22 |
| 2024-03-31 | $2.7M | 349k | 7.71 |
| 2023-12-31 | $3.5M | 392k | 8.99 |
| 2023-09-30 | $4.3M | 484k | 8.94 |
| 2023-06-30 | $11M | 729k | 15.36 |
| 2023-03-31 | $25M | 1.1M | 22.08 |
| 2022-12-31 | $26M | 1.2M | 20.89 |
| 2022-06-30 | $26M | 1.1M | 23.79 |
| 2022-03-31 | $28M | 1.1M | 25.62 |
| 2021-12-31 | $36M | 1.1M | 31.36 |
| 2021-03-31 | $724k | 29k | 24.98 |
| 2020-12-31 | $982k | 36k | 27.34 |